Clinical trials
Completed Phase 3 Leukemia, Myeloid, Chronic-Phase trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2002 | 3 |
| 2003 | 2 |
| 2005 | 2 |
| 2007 | 3 |
| 2008 | 6 |
| 2011 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 5 |
| Alliance for Clinical Trials in Oncology | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Vanderbilt-Ingram Cancer Center | 2 |
| Bristol-Myers Squibb | 1 |
| Case Comprehensive Cancer Center | 1 |
| Children's Oncology Group | 1 |
| Eastern Cooperative Oncology Group | 1 |
| Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Chronic-Phase | 31 |
| Leukemia, Myeloid, Accelerated Phase | 21 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 21 |
| Burkitt Lymphoma | 20 |
| Hodgkin Disease | 20 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 20 |
| Lymphoma, Large B-Cell, Diffuse | 20 |
| Lymphoma, Mantle-Cell | 20 |
| Blast Crisis | 19 |
| Lymphoma, B-Cell, Marginal Zone | 19 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.